Literature DB >> 33224789

Does ethnicity matter in chemotherapy for breast cancer?

Andrzej L Komorowski1, Maksymilian Kruczala2.   

Abstract

Entities:  

Year:  2020        PMID： 33224789      PMCID： PMC7667100          DOI： 10.21037/gs.2020.03.26

Source DB:  PubMed          Journal:  Gland Surg        ISSN： 2227-684X


× No keyword cloud information.
  5 in total

1.  Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial.

Authors:  Zhimin Shao; Da Pang; Hongjian Yang; Wei Li; Shusen Wang; Shude Cui; Ning Liao; Yongsheng Wang; Chuan Wang; Yuan-Ching Chang; Hweichung Wang; Seok Yun Kang; Jae Hong Seo; Kunwei Shen; Suphawat Laohawiriyakamol; Zefei Jiang; Junjie Li; Julian Zhou; Betsy Althaus; Yixiang Mao; Jennifer Eng-Wong
Journal:  JAMA Oncol       Date:  2020-03-12       Impact factor: 31.777

2.  Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer.

Authors:  Hyo Sook Han; Isildinha M Reis; Wei Zhao; Katsumasa Kuroi; Masakazu Toi; Eiji Suzuki; Rachel Syme; Louis Chow; Adrian Y S Yip; Stefan Glück
Journal:  Eur J Cancer       Date:  2011-07-07       Impact factor: 9.162

3.  Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.

Authors:  Luca Gianni; Tadeusz Pienkowski; Young-Hyuck Im; Laslo Roman; Ling-Ming Tseng; Mei-Ching Liu; Ana Lluch; Elżbieta Staroslawska; Juan de la Haba-Rodriguez; Seock-Ah Im; Jose Luiz Pedrini; Brigitte Poirier; Paolo Morandi; Vladimir Semiglazov; Vichien Srimuninnimit; Giulia Bianchi; Tania Szado; Jayantha Ratnayake; Graham Ross; Pinuccia Valagussa
Journal:  Lancet Oncol       Date:  2011-12-06       Impact factor: 41.316

4.  Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients.

Authors:  L W C Chow; L Biganzoli; A D Leo; K Kuroi; H S Han; J Patel; C S Huang; Y S Lu; L Zhu; C Y C Chow; W T Y Loo; S Glück; M Toi
Journal:  Asia Pac J Clin Oncol       Date:  2017-03-28       Impact factor: 2.601

5.  Impact of different type of cancer treatment on the effectiveness of breast reconstruction.

Authors:  Joanna Szloch; Elżbieta Marczyk; Marta Kołodziej-Rzepa; Andrzej L Komorowski
Journal:  Gland Surg       Date:  2016-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.